Coloplast A/S Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PG | Procter & Gamble | Outperform |
12
|
$163.20 | $166.80 | 6.62% | 5 | $385.17B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$144.59 | $174.55 | 17.57% | 3 | $348.43B |
| PFE | Pfizer | Outperform |
2
|
$25.62 | $32.87 | 19.05% | 6 | $145.07B |
| ULVR | Unilever PLC | Hold |
8
|
£41.40 | £50.61 | 20.87% | 12 | £103.61B |
| SAN | Sanofi | Outperform |
16
|
93.08€ | 102.80€ | 17.10% | 9 | 116.22€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$43.94 | $58.15 | 22.89% | 10 | $89.07B |
| RKT | Reckitt Benckiser Group | Outperform |
12
|
£44.68 | £66.68 | 20.86% | 12 | £31.50B |
| BEI | Beiersdorf | Outperform |
17
|
140.55€ | 137.41€ | 6.01% | 3 | 31.46€B |
| BAYN | Bayer | Hold |
5
|
27.35€ | 45.15€ | 9.69% | 4 | 26.87€B |
| CLX | Clorox Co-The | Hold |
16
|
$147.87 | $154.18 | 4.82% | 9 | $18.35B |
| SN. | Smith & Nephew | Outperform |
18
|
£9.79 | £16.09 | 67.62% | 10 | £8.54B |
| CTEC | ConvaTec Group PLC | Outperform |
16
|
£2.50 | £3.43 | 58.80% | 6 | £5.12B |
| PRGO | Perrigo Co PLC | Buy |
16
|
$32.66 | $44.75 | 21.25% | 0 | $4.17B |
| HYPE3 | Hypera | Outperform |
16
|
R$29.52 | R$45.97 | 39.74% | 3 | R$18.07B |
| AXNX | Axonics | Hold |
7
|
$66.57 | $70.15 | 6.65% | 2 | $3.40B |
| IART | Integra LifeSciences Holdings | Hold |
16
|
$29.17 | $46.60 | 49.13% | 4 | $2.23B |
| ORGO | Organogenesis Holdings | Outperform |
10
|
$2.35 | $4.75 | 112.77% | 1 | $468.79M |
| CLGN | CollPlant Biotechnologies | Buy |
7
|
$5.55 | $0.00 | 204.14% | 0 | $65.00M |
| 540468 | KMS Medisurgi | - |
0
|
34.35 | 0.00 | -100.00% | 0 | 113.03M |